Kaplan Fox investigates multiple companies for potential securities violations

Law firm Kaplan Fox & Kilsheimer LLP has announced investigations into several companies regarding potential securities law violations.

Alignment Healthcare, Inc. is under investigation following a whistleblower complaint alleging accounting irregularities. The complaint claims the company misclassified operating expenses as capital expenditures to artificially inflate financial metrics, including Adjusted EBITDA. This news led to a 16.7% drop in stock price in July 2026.

The Ensign Group, Inc. is being investigated following a report by Hunterbrook Media. The report alleged that the company’s business model involved delivering inadequate patient care and gaming quality data. The company's stock fell 8.15% following these allegations.

Fulcrum Therapeutics, Inc. is also facing investigation after announcing the discontinuation of its pociredir program for sickle cell disease. The decision followed FDA concerns regarding malignancy risks associated with similar pharmacological interventions, resulting in a 51.09% decline in the company's stock price.